Tonix Pharmaceuticals Holding Corp.
TNXP
$17.82
$0.633.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -31.68% | -29.26% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -31.68% | -29.26% | -- | -- | -- |
| Cost of Revenue | -50.02% | -34.50% | -- | -- | -- |
| Gross Profit | -0.92% | -21.55% | -- | -- | -- |
| SG&A Expenses | 34.08% | -11.54% | 6.77% | 25.96% | 44.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.44% | -42.82% | -29.08% | -29.70% | -4.95% |
| Operating Income | 17.74% | 44.74% | 36.70% | 37.02% | 16.50% |
| Income Before Tax | 19.08% | 49.19% | -177.81% | 54.74% | 13.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 19.08% | 49.19% | -177.81% | 54.74% | 13.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.08% | 49.19% | -177.81% | 54.74% | 13.76% |
| EBIT | 17.74% | 44.74% | 36.70% | 37.02% | 16.50% |
| EBITDA | 16.73% | 44.63% | 38.06% | 38.26% | 19.01% |
| EPS Basic | 99.55% | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | 99.55% | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 18,008.00% | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |